Endothelial cell activation in a VEGF-A gradient: Relevance to cell fate decisions

Microvascular Research

Volumn 80, Issue 1, 2010, Pages 65-74

  Akeson, A ^a   Herman, Amanda ^a   Wiginton, Diane ^a   Greenberg, James ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Cell fate; Microvascular; Morphogen; Organogenesis

Indexed keywords

DOWN SYNDROME CRITICAL REGION PROTEIN 1; EARLY GROWTH RESPONSE FACTOR 1; EARLY GROWTH RESPONSE FACTOR 3; GENE PRODUCT; IMMEDIATE EARLY PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NUCLEAR RECEPTOR NUR77; NUCLEAR RECEPTOR RELATED FACTOR 1; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ARTICLE; AUTOPHOSPHORYLATION; CELL ACTIVATION; CELL FATE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TIME;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EARLY GROWTH RESPONSE PROTEIN 1; EARLY GROWTH RESPONSE PROTEIN 3; EMBRYO, MAMMALIAN; ENDOTHELIAL CELLS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; LUNG; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE PROTEINS; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; TYROSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 77953544765     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2010.02.001     Document Type: Article

References (41)

1. Akeson A.L., et al. Embryonic vasculogenesis by endothelial precursor cells derived from lung mesenchyme. Dev. Dyn. 2000, 217:11-23.
2. Akeson A.L., et al. Temporal and spatial regulation of VEGF-A controls vascular patterning in the embryonic lung. Dev. Biol. 2003, 264:443-455.
3. Armesilla A.L., et al. Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: a role for tissue factor gene expression. Mol. Cell. Biol. 1999, 19:2032-2043.
4. Ashe H.L., Briscoe J. The interpretation of morphogen gradients. Development 2006, 133:385-394.
5. Benedito R., et al. The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 2009, 137:1124-1135.
6. Carmeliet P., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439.
7. Dayanir V., et al. Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. J. Biol. Chem. 2001, 276:17686-17692.
8. Ferrara N. Vascular endothelial growth factor. Eur. J. Cancer 1996, 32A:2413-2422.
9. Ferrara N., et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380:439-442.
10. Galambos C., et al. Defective pulmonary development in the absence of heparin-binding vascular endothelial growth factor isoforms. Am. J. Respir. Cell Mol. Biol. 2002, 27:194-203.
11. Gerhardt H., et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 2003, 161:1163-1177.
12. Greenberg J.M., et al. Mesenchymal expression of vascular endothelial growth factors D and A defines vascular patterning in developing lung. Dev. Dyn. 2002, 224:144-153.
13. Gurdon J.B., Bourillot P.Y. Morphogen gradient interpretation. Nature 2001, 413:797-803.
14. Haigh J.J. Role of VEGF in organogenesis. Organogenesis 2008, 4:247-256.
15. Harfe B.D., et al. Evidence for an expansion-based temporal Shh gradient in specifying vertebrate digit identities. Cell 2004, 118:517-528.
16. Ibanes M., Belmonte J.C. Theoretical and experimental approaches to understand morphogen gradients. Mol. Syst. Biol. 2008, 4:176.
17. Jaeger J., et al. Regulative feedback in pattern formation: towards a general relativistic theory of positional information. Development 2008, 135:3175-3183.
18. Kappas N.C., et al. The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching. J. Cell Biol. 2008, 181:847-858.
19. Kholodenko B.N. Cell-signalling dynamics in time and space. Nat. Rev. Mol. Cell Biol. 2006, 7:165-176.
20. Liu L., et al. Egr-1 gene is induced by the systemic administration of the vascular endothelial growth factor and the epidermal growth factor. Blood 2000, 96:1772-1781.
21. Liu D., et al. The zinc-finger transcription factor, early growth response 3, mediates VEGF-induced angiogenesis. Oncogene 2008, 27:2989-2998.
22. Mac Gabhann F., Popel A.S. Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2004, 286:H153-164.
23. Mac Gabhann F., Popel A.S. Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H459-474.
24. Mallory B.P., et al. Lymphangiogenesis in the developing lung promoted by VEGF-A. Microvasc. Res. 2006, 72:62-73.
25. Matsumoto T., et al. VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. EMBO J. 2005, 24:2342-2353.
26. Minami T., et al. Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J. Biol. Chem. 2004, 279:50537-50554.
27. Ng Y.S., et al. Differential expression of VEGF isoforms in mouse during development and in the adult. Dev. Dyn. 2001, 220:112-121.
28. Olsson A.K., et al. VEGF receptor signalling-in control of vascular function. Nat. Rev. Mol. Cell Biol. 2006, 7:359-371.
29. Pan Q., et al. Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting. J. Biol. Chem. 2007, 282:24049-24056.
30. Ponder B.A., et al. An allelic difference determines reciprocal patterns of expression of binding sites for Dolichos biflorus lectin in inbred strains of mice. J. Embryol. Exp. Morphol. 1985, 87:229-239.
31. Ruhrberg C., et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev. 2002, 16:2684-2698.
32. Sakurai Y., et al. Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:1076-1081.
33. Schachtner S., Wang YQ, Baldwin HS. Qualitative and quantitative analysis of embryonic pulmonary vessel formation. Am. J. Respir. Cell Mol. Biol. 2000, 22:157-165.
34. Schwarz M.A., et al. Emerging pulmonary vasculature lacks fate specification. Am. J. Physiol. Lung Cell Mol. Physiol. 2009, 296:L71-81.
35. Schweighofer B., et al. Signals and genes induced by angiogenic growth factors in comparison to inflammatory cytokines in endothelial cells. Clin. Hemorheol. Microcirc. 2007, 37:57-62.
36. Siekmann A.F., et al. Modulation of VEGF signalling output by the Notch pathway. Bioessays 2008, 30:303-313.
37. Soker S., et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998, 92:735-745.
38. Takahashi T., et al. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J. 2001, 20:2768-2778.
39. Wang D., et al. Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 282:G1088-1096.
40. Watkins R.H., et al. Differential expression of VEGF mRNA splice variants in newborn and adult hyperoxic lung injury. Am. J. Physiol. 1999, 276:L858-867.
41. Zeng H., et al. Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively. J. Biol. Chem. 2001, 276:32714-32719.